Genix Pharmaceuticals (GENP.F) Stock Overview

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. More details

GENP.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Negative shareholders equity

Makes less than USD$1m in revenue (CA$0)

Shares are highly illiquid

Does not have a meaningful market cap ($1M)

+ 1 more risk

GENP.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Genix Pharmaceuticals Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Genix Pharmaceuticals
Historical stock prices
Current Share Price	CA$0.014
52 Week High	CA$0.036
52 Week Low	CA$0.014
Beta	0.49
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	-92.08%
Change since IPO	-92.33%

Recent updates

Shareholder Returns

	GENP.F	US Personal Products	US Market
7D	0%	-9.2%	-2.3%
1Y	n/a	-10.8%	17.1%

Return vs Industry: Insufficient data to determine how GENP.F performed against the US Personal Products industry.

Return vs Market: Insufficient data to determine how GENP.F performed against the US Market.

Price Volatility

Is GENP.F's price volatile compared to industry and market?
GENP.F volatility
GENP.F Average Weekly Movement	n/a
Personal Products Industry Average Movement	8.7%
Market Average Movement	6.7%
10% most volatile stocks in US Market	16.2%
10% least volatile stocks in US Market	3.2%

Stable Share Price: GENP.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine GENP.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1993	n/a	Sina Pirooz	genixpharm.com

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults; and Synthroid, a levothyroxine sodium drug for the treatment of hypothyroidism.

Genix Pharmaceuticals Corporation Fundamentals Summary

How do Genix Pharmaceuticals's earnings and revenue compare to its market cap?
GENP.F fundamental statistics
Market cap	US$895.92k
Earnings (TTM)	-US$245.15k
Revenue (TTM)	n/a

0.0x

P/S Ratio

-3.7x

P/E Ratio

Is GENP.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GENP.F income statement (TTM)
Revenue	CA$0
Cost of Revenue	CA$0
Gross Profit	CA$0
Other Expenses	CA$335.06k
Earnings	-CA$335.05k

Last Reported Earnings

Oct 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0055
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	-73.5%

How did GENP.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/03/06 17:40
End of Day Share Price	2026/01/20 00:00
Earnings	2025/10/31
Annual Earnings	2025/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genix Pharmaceuticals Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Genix Pharmaceuticals CorporationOTCPK:GENP.F Stock Report